Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-01-01 @ 10:09 AM
Study NCT ID:
NCT06287450
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-12-03
First Post:
2024-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults
Sponsor:
Shenzhen Shenxin Biotechnology Co., Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Respiratory Syncytial Virus Infections | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | mRNA Vaccine | View |
| None | IN006 | View |
| None | Respiratory syncytial virus | View |
| None | Viral Diseases | View |
| None | Messenger RNA | View |
| None | Innorna | View |
| None | Shenxin | View |
| None | Vaccines | View |
| None | Respiratory tract infections | View |
| None | Safety | View |
| None | Reactogenicity | View |
| None | Immunogenicity | View |
| None | RSV | View |